{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:16Z","timestamp":1786982116342,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s11886-004-0071-2","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T05:47:26Z","timestamp":1180158446000},"page":"243-252","source":"Crossref","is-referenced-by-count":22,"title":["Acute coronary syndromes in women: Is treatment different? should it be?"],"prefix":"10.1007","volume":"6","author":[{"given":"Susan K.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita F.","family":"Redberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"71_CR1","volume-title":"Committee on Understanding the Biology of Sex and Gender Differences, Board on Health Sciences Policy, Institute of Medicine","author":"T Wizemann","year":"2001","unstructured":"Wizemann T, Pardue M: Exploring the Biological Contributions to Human Health: Does Sex Matter? Committee on Understanding the Biology of Sex and Gender Differences, Board on Health Sciences Policy, Institute of Medicine. Washington, DC: Nationa Academy Press; 2001."},{"key":"71_CR2","volume-title":"Heart Disease and Stroke Statistics \u2014 2004 Update","author":"American Heart Association","year":"2003","unstructured":"American Heart Association: Heart Disease and Stroke Statistics \u2014 2004 Update. Dallas: American Heart Association; 2003."},{"key":"71_CR3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000114834.85476.81","volume":"109","author":"L Mosca","year":"2004","unstructured":"Mosca L, Appel L, Benjamin E, et al.: Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004, 109:672\u2013692.","journal-title":"Circulation"},{"key":"71_CR4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration: Collaborative overview of randomized trials of antiplatelet therapy prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994, 308:81\u2013106. A major meta-analysis evaluating the effects of aspirin in patients with CAD.","journal-title":"Br Med J"},{"key":"71_CR5","first-page":"349","volume":"ii","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected myocardial infarction (ISIS-2). Lancet 1988, ii:349\u2013360.","journal-title":"Lancet"},{"key":"71_CR6","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, et al.: Beta-blockade after myocardial infarction: systematic review and meta regression analysis. Br Med J 1999, 318:1730\u20131737.","journal-title":"Br Med J"},{"key":"71_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/9.suppl_L.8","volume":"9","author":"The Beta-Blocker Pooling Research Group","year":"1988","unstructured":"The Beta-Blocker Pooling Research Group: The Beta-Blocker Pooling Project (BBPP): subgroup findings for randomized trials in post infarction patients. Eur Heart J 1988, 9:8\u201316.","journal-title":"Eur Heart J"},{"key":"71_CR8","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0002-9149(87)90492-9","volume":"60","author":"P Sleight","year":"1987","unstructured":"Sleight P: Beta-blockade early in acute myocardial infarction. Am J Cardiol 1987, 60:6A-10A.","journal-title":"Am J Cardiol"},{"key":"71_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","volume":"83","author":"R Roberts","year":"1991","unstructured":"Roberts R, Rogers W, Mueller H, Lambrew, et al.: Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Circulation 1991, 83:422\u2013437.","journal-title":"Circulation"},{"key":"71_CR10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1001\/archinte.163.18.2175","volume":"163","author":"H Silvet","year":"2003","unstructured":"Silvet H, Spencer F, Yarzebski J, et al.: Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction. Arch Intern Med 2003, 163:2175\u20132183.","journal-title":"Arch Intern Med"},{"key":"71_CR11","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","volume":"97","author":"ACE Inhibitor Myocardial Infarction Collaborative Group","year":"1998","unstructured":"ACE Inhibitor Myocardial Infarction Collaborative Group: Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Circulation 1998, 97:2202\u20132212.","journal-title":"Circulation"},{"key":"71_CR12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"M Flather","year":"2000","unstructured":"Flather M, Yusuf S, Kober L, et al.: Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000, 355:1575\u20131581. The most comprehensive meta-analysis to date that evaluates the effects of ACE inhibitors in post-MI patients.","journal-title":"Lancet"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"M Pfeffer","year":"2003","unstructured":"Pfeffer M, McMurray J, Velazquez E, et al.: Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003, 349:1893\u20131906.","journal-title":"N Engl J Med"},{"key":"71_CR14","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.163.12.1430","volume":"163","author":"D Burwen","year":"2003","unstructured":"Burwen D, Galashu D, Lewis J, et al.: National and state trends in quality of care for acute myocardial infarction between 1994- 1995 and 1998-1999. Arch Intern Med 2003, 163:1430\u20131439.","journal-title":"Arch Intern Med"},{"key":"71_CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","author":"Fibrinolytic Therapy Trialists\u2019 (FTT) Collaborative Group","year":"1994","unstructured":"Fibrinolytic Therapy Trialists\u2019 (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343:311\u2013322.","journal-title":"Lancet"},{"key":"71_CR16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.1996.03530340041027","volume":"275","author":"WD Weaver","year":"1996","unstructured":"Weaver WD, White H, Wilcox R, et al.: Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 1996, 275:777\u2013782.","journal-title":"JAMA"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/01.CIR.88.5.2097","volume":"88","author":"H White","year":"1993","unstructured":"White H, Barbash G, Modan M, et al.: After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality as men except for a higher incidence of hemorraghic stroke. Circulation 1993, 88[Part 1]:2097\u20132103. One of the first papers to utilize multivariate analysis to explain sex differences in CHD outcome.","journal-title":"Circulation"},{"key":"71_CR18","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1161\/01.CIR.92.10.2811","volume":"92","author":"J Gore","year":"1995","unstructured":"Gore J, Granger C, Simoons M, et al.: Stroke after thrombolysis; mortality and functional outcomes in the GUSTO-1 trial. Circulation 1995, 92:2811\u20132818.","journal-title":"Circulation"},{"key":"71_CR19","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/01.CIR.95.11.2508","volume":"95","author":"S Berkowitz","year":"1997","unstructured":"Berkowitz S, Granger C, Pieper K, et al.: Incidence and predictors of bleeding after contemporary thrombolytic therapy for acute myocardial infarction. Circulation 1997, 95:2508\u20132516.","journal-title":"Circulation"},{"key":"71_CR20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","author":"Assessment of the Safety and Efficacy of a New Thrombolytic Investigators","year":"1999","unstructured":"Assessment of the Safety and Efficacy of a New Thrombolytic Investigators: Single-bolus tenecteplase compared to frontloaded alteplase in acute myocardial infarction. Lancet 1999, 354:716\u2013722.","journal-title":"Lancet"},{"key":"71_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","volume":"356","author":"L Wallentin","year":"2000","unstructured":"Wallentin L, Lagerqvist B, Husted S, et al.: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 2000, 356:9\u201316.","journal-title":"Lancet"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(00)02552-6","volume":"356","author":"S Mehta","year":"2000","unstructured":"Mehta S, Eikelboom J, Yusuf S: Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis. Lancet 2000, 356:449\u2013454.","journal-title":"Lancet"},{"key":"71_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(02)07595-5","volume":"359","author":"K Eagle","year":"2002","unstructured":"Eagle K, Goodman S, Avezum A, et al.: Practice variation and missed opportunities for reperfusion in st-segment elevation myocardial infarction: finding from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373\u2013377.","journal-title":"Lancet"},{"key":"71_CR24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.whi.2003.09.002","volume":"13","author":"S Grace","year":"2003","unstructured":"Grace S, Abbey S, Bisaillon S, et al.: Presentation, delay and contraindication to thrombolytic treatment in females and males with myocardial infarction. Womens Health Issues 2003, 13:214\u2013221.","journal-title":"Womens Health Issues"},{"key":"71_CR25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/euhj.2001.2901","volume":"23","author":"F Zijlstra","year":"2002","unstructured":"Zijlstra F, Patel A, Jones M: Clinical characteristics and outcome of patients with early (< 2h), intermediate (2-4 h) and late (> 4 h) presentation treated by primary angioplasty or thrombolytic therapy. Eur Heart J 2002, 23:550\u2013557.","journal-title":"Eur Heart J"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0735-1097(02)01835-1","volume":"39","author":"A Jacobs","year":"2002","unstructured":"Jacobs A, Johnton J, Haviland A, et al.: Improved outcomes for women undergoing contemporary percutaneous intervention. J Am Coll Cardiol 2002, 39:1608\u20131614.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9149(01)01721-0","volume":"88","author":"F Welty","year":"2001","unstructured":"Welty F, Lewis S, Kowalker W, Shubrooks S: Reason for higher in-hospital mortality > 24 hours after percutaneous transluminal coronary angioplasty in women compared to men. Am J Cardiol 2001, 88:473\u2013477.","journal-title":"Am J Cardiol"},{"key":"71_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1525-1497.2003.20929.x","volume":"18","author":"L Harrold","year":"2003","unstructured":"Harrold L, Esteban J, Lessard D, et al.: Narrowing gender differences in procedure use for acute myocardial infarction. J Gen Intern Med 2003, 18:423\u2013431. One of few studies that evaluated temporal changes in procedure use in an unselected population.","journal-title":"J Gen Intern Med"},{"key":"71_CR29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM200007063430102","volume":"343","author":"S Gan","year":"2000","unstructured":"Gan S, Beaver S, Houck P, et al.: Treatment of acute myocardial infarction and 30-day mortality among men and women. N Engl J Med 2000, 343:8\u201315. One of the largest studies to evaluate outcome by sex; it looked at the Medicare MI population to determine if \"ideal candidates\" were referred for coronary angiography.","journal-title":"N Engl J Med"},{"key":"71_CR30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archinte.158.9.981","volume":"158","author":"N Chandra","year":"1998","unstructured":"Chandra N, Ziegelstein R, Rogers W, et al.: Observations of the treatment of women in the United States with myocardial infarction. Arch Intern Med 1998, 158:981\u2013988.","journal-title":"Arch Intern Med"},{"key":"71_CR31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.283.5.646","volume":"283","author":"V Roger","year":"2000","unstructured":"Roger V, Farkouh M, Weston S, et al.: Sex differences in evaluation and outcome of unstable angina. JAMA 2000, 283:646\u2013652.","journal-title":"JAMA"},{"key":"71_CR32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"C Cannon","year":"2001","unstructured":"Cannon C, Weintraub W, Demopoulos L: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879\u20131887.","journal-title":"N Engl J Med"},{"key":"71_CR33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9149(99)80709-7","volume":"75","author":"G Stone","year":"1995","unstructured":"Stone G, Grines C, Browne K, et al.: Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995, 75:987\u2013992. Ad-hoc analysis of the PAMI data comparing lytics with angioplasty.","journal-title":"Am J Cardiol"},{"key":"71_CR34","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1161\/hc5001.101060","volume":"104","author":"B Vakili","year":"2001","unstructured":"Vakili B, Kaplan R, Brown D: Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation 2001, 104:3034\u20133038.","journal-title":"Circulation"},{"key":"71_CR35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","volume":"341","author":"C Grines","year":"1999","unstructured":"Grines C, Cox D, Stone G, et al.: Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999, 341:1949\u20131956.","journal-title":"N Engl J Med"},{"key":"71_CR36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pcad.2003.08.004","volume":"46","author":"A Lansky","year":"2004","unstructured":"Lansky A: Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis 2004, 46:305\u2013319. Very comprehensive recent overview of revascularization in women; cites over 90 studies.","journal-title":"Prog Cardiovasc Dis"},{"key":"71_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0002-9149(00)01360-6","volume":"87","author":"D Antoniucci","year":"2001","unstructured":"Antoniucci D, Valenti R, Moschi G, et al.: Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2001, 87:289\u2013293.","journal-title":"Am J Cardiol"},{"key":"71_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"E Keeley","year":"2003","unstructured":"Keeley E, Boura J, Grines C: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13\u201320.","journal-title":"Lancet"},{"key":"71_CR39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","volume":"109","author":"D Holmes","year":"2004","unstructured":"Holmes D, Leon M, Moses J, et al.: Analysis of 1-year clinical outcomes in the SIRIUS trial. Circulation 2004, 109:634\u2013640.","journal-title":"Circulation"},{"key":"71_CR40","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/01.CIR.0000096053.87580.CD","volume":"108","author":"F Saia","year":"2003","unstructured":"Saia F, Lemos P, Lee C-H, et al.: Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. Circulation 2003, 108:1927\u20131929.","journal-title":"Circulation"},{"key":"71_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","volume":"359","author":"E Boersma","year":"2002","unstructured":"Boersma E, Harrington R, Moliterno D, et al.: Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002, 359:189\u2013198. One of two meta-analyses that evaluate the efficacy and safety of GP IIb\/IIIa inhibitors in women.","journal-title":"Lancet"},{"key":"71_CR42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0735-1097(00)00746-4","volume":"36","author":"L Cho","year":"2000","unstructured":"Cho L, Topol E, Balog C, et al.: Clinical benefit of glycoprotein IIb\/IIIa blockade with abciximab is independent of gender. J Am Coll Cardiol 2000, 36:381\u2013386.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR43","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","volume":"355","author":"J Eikelboom","year":"2000","unstructured":"Eikelboom J, Anand S, Malmberg K, et al.: Unfractionated heparin and low-molecular weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000, 355:1936\u20131942.","journal-title":"Lancet"},{"key":"71_CR44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"M Cohen","year":"1997","unstructured":"Cohen M, Demers C, Gurfinkel E, et al.: A comparison of lowmolecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447\u2013452.","journal-title":"N Engl J Med"},{"key":"71_CR45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"E Antman","year":"1999","unstructured":"Antman E, McCabe C, Gurfinkel E: Enoxaparin prevents death and cardiac ischaemic events in unstable angina\/non-Qwave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation 1999, 100:1593\u20131601.","journal-title":"Circulation"},{"key":"71_CR46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","volume":"358","author":"The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators","year":"2001","unstructured":"The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001, 358:605\u2013613.","journal-title":"Lancet"},{"key":"71_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.0000081659.72985.A8","volume":"108","author":"L Wallentin","year":"2003","unstructured":"Wallentin L, Goldstein P, Armstrong P: Efficacy and safety of tenecteplase in combination with the low-molecular weight heparin enoxaparin or unfractionated heparin in the prehospital setting. Circulation 2003, 108:135\u2013142.","journal-title":"Circulation"},{"key":"71_CR48","unstructured":"Wallentin L: ASSENT-3: one-year follow-up; 2002. 18th International Symposium on Thrombolysis and Interventional Therapy in Acute Myocardial Infarction. Chicago, IL: November 16, 2002."},{"key":"71_CR49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(02)07495-0","volume":"359","author":"The Direct Thrombin Inhibitors Trialists\u2019 Collaborative Group","year":"2002","unstructured":"The Direct Thrombin Inhibitors Trialists\u2019 Collaborative Group: Direct thrombin inhibitors in acute coronary syndroms: principal results of a meta-analysis based on individual patient\u2019s data. Lancet 2002, 359:294\u2013302.","journal-title":"Lancet"},{"key":"71_CR50","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","volume":"358","author":"The Hirulog and Early Perfusion or Occlusion (HERO)-2 Trial Investigators","year":"2001","unstructured":"The Hirulog and Early Perfusion or Occlusion (HERO)-2 Trial Investigators: Thrombin-specific anticoagulation with bilvalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001, 358:1855\u20131863.","journal-title":"Lancet"},{"key":"71_CR51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators","year":"2001","unstructured":"The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators: Effects of clopidogrel in addition to asprin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494\u2013502.","journal-title":"N Engl J Med"},{"key":"71_CR52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"S Mehta","year":"2001","unstructured":"Mehta S, Yusuf S, Peters R, Bertrand M: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoin percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:527\u2013533.","journal-title":"Lancet"},{"key":"71_CR53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","volume":"360","author":"K Fox","year":"2002","unstructured":"Fox K, Poole-Wilson P, Henderson R, et al.: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA-3 randomised trial. Lancet 2002, 360:743\u2013751.","journal-title":"Lancet"},{"key":"71_CR54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","volume":"354","author":"FRagmin and Fast Revascularization during InStability in Coronary Artery Disease (FRISC II) Investigators","year":"1999","unstructured":"FRagmin and Fast Revascularization during InStability in Coronary Artery Disease (FRISC II) Investigators: Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999, 354:708\u2013715.","journal-title":"Lancet"},{"key":"71_CR55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1072-7515(02)01756-8","volume":"196","author":"S Woods","year":"2003","unstructured":"Woods S, Noble G, Smith JM, Hasselfeld K: The influence of gender in patients undergoing coronary artery bypass surgery: an eight-year prospective hospitalized cohort study. J Am Coll Surg 2003, 196:428\u2013434. Reports on the analysis of the STS database, the largest nonselected cohort of surgery patients.","journal-title":"J Am Coll Surg"},{"key":"71_CR56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/hc1002.105133","volume":"105","author":"V Vaccarino","year":"2002","unstructured":"Vaccarino V, Abramson J, Veledar E, Weintraub W: Sex differences in hospital mortality after coronary artery bypass surgery. Circulation 2002, 105:1176\u20131181.","journal-title":"Circulation"},{"key":"71_CR57","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/01.CIR.103.17.2133","volume":"103","author":"C Hogue","year":"2001","unstructured":"Hogue C, Barzilai B, Pieper K, et al.: Sex differences in neurologic outcomes and mortality after cardiac surgery. Circulation 2001, 103:2133\u20132137.","journal-title":"Circulation"},{"key":"71_CR58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0003-4975(02)03636-6","volume":"74","author":"S Stamou","year":"2002","unstructured":"Stamou S, Jablonski K, Pfister A, et al.: Stroke after conventional versus minimally invasive coronary artery bypass. Ann Thorac Surg 2002, 74:394\u2013399.","journal-title":"Ann Thorac Surg"},{"key":"71_CR59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(02)02698-0","volume":"41","author":"V Vaccarino","year":"2003","unstructured":"Vaccarino V, Zhen QL, Kasl S, et al.: Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol 2003, 41:307\u2013314.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199907223410401","volume":"341","author":"V Vaccarino","year":"1999","unstructured":"Vaccarino V, Parsons L, Every N, et al.: Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999, 341:217\u2013225. Landmark paper that describes the higher mortality in younger women with CHD.","journal-title":"N Engl J Med"},{"key":"71_CR61","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0735-1097(01)01465-6","volume":"38","author":"K MacIntyre","year":"2001","unstructured":"MacIntyre K, Stewart S, Capewell S, et al.: Gender and survival: a population-based study of 201,114 men and women following a first myocardial infarction. J Am Coll Cardiol 2001, 38:729\u2013735.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR62","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/archinte.163.20.2476","volume":"163","author":"W Chang","year":"2003","unstructured":"Chang W, Kaul P, Westerhout C, et al.: Impact of sex on longterm mortality from acute myocardial infarction vs. unstable angina. Arch Intern Med 2003, 163:2476\u20132484.","journal-title":"Arch Intern Med"},{"key":"71_CR63","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jama.291.10.1220","volume":"291","author":"K King","year":"2004","unstructured":"King K, Ghali W, Faris P, et al.: Sex differences in outcomes after cardiac catheterization. JAMA 2004, 291:1220\u20131225.","journal-title":"JAMA"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-004-0071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-004-0071-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-004-0071-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:00Z","timestamp":1559418960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-004-0071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s11886-004-0071-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}